4.7 Article

Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy

Related references

Note: Only part of the references are listed.
Review Chemistry, Multidisciplinary

Arsenic trioxide: safety issues and their management

Wing-Yan Au et al.

ACTA PHARMACOLOGICA SINICA (2008)

Article Multidisciplinary Sciences

Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia

Lan Wang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Hematology

Treatment of relapsed or refractory acute promyelocytic leukemia

Martin S. Tallman

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)

Article Pharmacology & Pharmacy

Systemic availability of arsenic from oral arsenic-trioxide used to treat patients with hematological malignancies

CR Kumana et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)